The North America Syringes Market is a fast-evolving segment driven by rising healthcare needs, technological advancements in medical devices, and the increasing prevalence of chronic diseases. With significant investments by leading pharmaceutical companies and healthcare providers, robust market growth is anticipated through 2035.
The economic impact of tariffs on "North America Syringes Market".
Market Growth Drivers
Increasing prevalence of chronic diseases such as diabetes and cancer is driving demand for syringes in North America. Companies like Becton Dickinson (BD) are expanding their syringe manufacturing capacities to meet this rising need, ensuring greater availability and improved patient outcomes.
Ongoing vaccination programs against diseases such as influenza, COVID-19, and routine immunizations are fueling the demand for syringes. For instance, Cardinal Health has partnered with multiple government agencies to provide secure and sterile syringe products for mass immunization campaigns.
Market Trends
The adoption of safety-engineered syringes is on the rise due to heightened awareness about needlestick injuries and regulatory mandates. Companies such as Smiths Medical are launching new product lines featuring retractable needles and shielded syringes to enhance healthcare worker and patient safety.
A surge in technological innovation, including the development of prefilled syringes, is evident. Pfizer and other pharmaceutical players are increasingly utilizing prefilled syringes for vaccines and biological drugs to streamline dose administration and minimize the risk of contamination.
Market Opportunities
The rapid expansion of point-of-care testing and home-based healthcare creates new opportunities for compact, easy-to-use syringe products. Companies such as Terumo Medical Corporation are focusing on innovative designs catering to home healthcare needs.
Expansion into personalized medicine and injectable therapies, particularly in oncology and rare diseases, opens the door for customized syringe solutions that major market players, including Baxter International, are actively exploring.
North America Syringes Market Revenue (USD Million), 2020-2035
The chart shows a consistent upward trend in market revenue from 2020 to 2035. In 2020, the North America Syringes Market was valued at USD 6,400 Million, steadily increasing each year to reach USD 15,300 Million by 2035. The growth can be attributed to ongoing advancements in syringe technologies, widespread vaccination initiatives, and the rising prevalence of chronic diseases. Notably, the years 2024-2027 see an accelerated increase, reflective of recent healthcare investments and adoption of innovative products.
North America Syringes Market Share by Region, 2025
The pie chart displays market share distribution among North American regions in 2025. The United States leads with a dominant 67% share due to its advanced healthcare infrastructure and major production facilities. Canada holds a considerable portion at 21%, benefitting from robust vaccination and chronic disease management programs. Mexico follows with 8%, while Central America and the Caribbean account for 3% and 1% respectively, reflecting varying degrees of healthcare development and syringe adoption rates.
Recent Developments
In March 2024, Becton Dickinson (BD) announced the opening of a new state-of-the-art syringe manufacturing facility in Texas, enhancing their production capacity by 30%. This strategic move aims to meet rising demand across North America and strengthen supply chain resilience.
In May 2024, Smiths Medical launched its new line of safety syringes with integrated needle protection mechanisms designed to reduce needlestick injuries in clinical settings. This product launch aligns with new OSHA guidelines mandating the use of safety-engineered syringes in US healthcare facilities.
In February 2024, Cardinal Health entered into a major public-private partnership with Health Canada to supply advanced prefilled syringes for national vaccination and immunization programs, focusing on both efficiency and patient safety in light of recent infectious disease outbreaks.
Press Releases